Sign Up Today and Learn More About Science Corporation Stock
Invest in or calculate the value of your shares in Science Corporation or other pre-IPO companies through EquityZen's platform.
Science Corporation Stock (SCIE)
Science develops advanced medical technologies at the frontier of humanity's capabilities and understanding.
Science develops advanced medical technologies at the frontier of humanity's capabilities and understanding.
About Science Corporation Stock
Founded
2021
Industries
Software, Artificial Intelligence, Data and Analytics
Science develops advanced technologies with the goal to, over time, blur the line between medical devices and consumer electronics. Today we are focused on debilitating conditions for which there is a serious unmet medical need. As these technologies mature, they hold the potential to profoundly reshape the human condition.
Notable investors include Artis Ventures, Blake Byers and Jed McCaleb.
Science Corporation Press Mentions
Stay in the know about the latest news on Science Corporation
Why Brain Implants Are More Than A Sci-Fi Fantasy
ndtv • May 12, 2026
万博での技術実証を経て、「ミラブルテクノロジー＝次世代のインフラ」へ サイエンス20周年記念式典「感謝の集い」を開催
prtimes • Apr 27, 2026
The New Unicorn Count Reached A 4-Year High In March, Led By Robotics, Frontier Labs And AI Infrastructure
news • Apr 21, 2026
Top Tech News Today, April 15, 2026
techstartups • Apr 16, 2026
Science Corp is preparing to place its first brain sensor in a human, betting biology will beat electrodes
thenextweb • Apr 15, 2026
Join now and verify your accreditation status to gain access to:
- Science Corporation Current Valuation
- Science Corporation Stock Price
- Science Corporation Management
- Available deals in Science Corporation and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Science Corporation Cap Table and Funding History by Share Class and Liquidity Preferences
- Science Corporation Revenue and Financials
- Science Corporation Highlights
- Science Corporation Business Model
- Science Corporation Risk Factors
- Science Corporation Research Report from SACRA Research
Trading Science Corporation Stock
How to invest in Science Corporation stock?
Accredited investors can buy pre-IPO stock in companies like Science Corporation through EquityZen funds. These investments are made available by existing Science Corporation shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Science Corporation stock?
Shareholders can sell their Science Corporation stock through EquityZen's private company marketplace. EquityZen's network includes over 450K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 53K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
